Search research articles
Contact Us
Filters
Showing results (141-150 of 185) with videos related to
Page
of 19
Sort By:
Journal of Virology
|
January 11, 2013
Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis
Susanne Berchtold, Johanna Lampe, Timo Weiland, et al.
Scientific Reports
|
March 8, 2019
Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide
Judith Wendler, Bjoern O Schroeder, Dirk Ehmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 6, 2021
Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk score
Julia M Grottenthaler, Annette Konzelmann, Anette Stiegler, et al.
EMBO Reports
|
February 22, 2005
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo
André Lechel, Ande Satyanarayana, Zhenyu Ju, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
June 6, 2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival
Timm D Kirchhoff, Joerg S Bleck, Arne Dettmer, et al.
The Journal of Clinical Investigation
|
October 28, 2010
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells
Uta Kossatz, Kai Breuhahn, Benita Wolf, et al.
Communications Biology
|
January 9, 2021
Curbing gastrointestinal infections by defensin fragment modifications without harming commensal microbiota
Louis Koeninger, Lisa Osbelt, Anne Berscheid, et al.
World Journal of Gastroenterology
|
June 15, 2006
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma
Arne Dettmer, Timm-D Kirchhoff, Michael Gebel, et al.
The Journal of Clinical Investigation
|
June 8, 2011
Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice
Norman Woller, Sarah Knocke, Bettina Mundt, et al.
Frontiers in Immunology
|
February 21, 2020
Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis
Louis Koeninger, Nicole S Armbruster, Karoline Sidelmann Brinch, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 185) with videos related to
Sort By:
Page
of 19
Journal of Virology
|
January 11, 2013
Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis
Susanne Berchtold, Johanna Lampe, Timo Weiland, et al.
Scientific Reports
|
March 8, 2019
Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide
Judith Wendler, Bjoern O Schroeder, Dirk Ehmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 6, 2021
Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk score
Julia M Grottenthaler, Annette Konzelmann, Anette Stiegler, et al.
EMBO Reports
|
February 22, 2005
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo
André Lechel, Ande Satyanarayana, Zhenyu Ju, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
June 6, 2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival
Timm D Kirchhoff, Joerg S Bleck, Arne Dettmer, et al.
The Journal of Clinical Investigation
|
October 28, 2010
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells
Uta Kossatz, Kai Breuhahn, Benita Wolf, et al.
Communications Biology
|
January 9, 2021
Curbing gastrointestinal infections by defensin fragment modifications without harming commensal microbiota
Louis Koeninger, Lisa Osbelt, Anne Berscheid, et al.
World Journal of Gastroenterology
|
June 15, 2006
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma
Arne Dettmer, Timm-D Kirchhoff, Michael Gebel, et al.
The Journal of Clinical Investigation
|
June 8, 2011
Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice
Norman Woller, Sarah Knocke, Bettina Mundt, et al.
Frontiers in Immunology
|
February 21, 2020
Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis
Louis Koeninger, Nicole S Armbruster, Karoline Sidelmann Brinch, et al.
Page
of 19